Aspire Biopharma Holdings(ASBP)
$8.41+0.01 (+0.12%)
ASBP
Aspire Biopharma Holdings financials statements
$8.41
At close:+0.01 (+0.12%)
Aspire Biopharma Holdings (ASBP) Income Statement
194 Followers
Aspire Biopharma Holdings Income Statement
Last quarter (Q2 2026), Aspire Biopharma Holdings's total revenue was $63.10K. In Q2, Aspire Biopharma Holdings's net income was $-1.27M. See Aspire Biopharma Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 6.20K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -116.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 19.35M | $ 1.21M | $ 1.34M | $ 976.35K | $ 25.48K | |
| Depreciation and Amortization | $ 8.02M | $ 0.00 | $ 1.34M | $ 0.00 | $ 27.79K |
| $ -11.33M | $ -1.21M | $ 5.81M | $ -976.35K | $ 2.32K | |
| $ -19.35M | $ -1.21M | $ -1.34M | $ -976.35K | $ -25.48K | |
| $ -5.13M | $ -97.99K | $ 5.80M | $ 4.32M | $ 5.00 | |
| $ -24.48M | $ -1.31M | $ 4.46M | $ 3.34M | $ -25.48K | |
| $ -24.48M | $ -1.31M | $ 4.46M | $ 3.34M | $ -25.48K | |
| Per Share Metrics | |||||
| Basic EPS | $ -16.38 | $ -34.17 | $ 9.31 | $ 3.72 | $ -0.04 |
| Diluted EPS | $ -16.38 | $ -34.17 | $ 9.31 | $ 3.72 | $ -0.04 |
| Weighted Average Shares Outstanding | 1.49M | 38.34K | 479.48K | 898.44K | 682.81K |
| Weighted Average Shares Outstanding (Diluted) | 1.49M | 38.34K | 479.48K | 898.44K | 682.81K |
Currency in USD
